Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07502729

Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,066 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the impact of high-risk factors-such as elevated portal venous pressure, concurrent large extra-luminal vessels, portal vein thrombosis, and prominent portosystemic shunts-on the efficacy of endoscopic therapy. By comparing with interventional treatment, the goal is to optimize the clinical management protocol for esophageal and gastric varices, enhance the therapeutic outcomes of portal hypertension-related esophageal and gastric varices, and improve patient prognosis.

Conditions

Timeline

Start date
2026-03-17
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2026-03-31
Last updated
2026-03-31

Source: ClinicalTrials.gov record NCT07502729. Inclusion in this directory is not an endorsement.